Please assess the completion status of the following clinical trial:

Trial Title: [124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Males or females age \>18 years~2. Ability to provide informed consent~3. A plain anterior-posterior (AP) and frog leg lateral X-ray of the hip or knee within 6 weeks of enrollment~4. Need for operative intervention in the opinion of the surgeon to correct the pain in the prosthetic joint~5. Prosthetic joint implant that has been in site for more than 3 months prior to enrolment~6. Having adequate general health to be expected to tolerate surgery adn to survive for 6 months from the time of informed consent~7. Women must be either postmenopausal or surgically sterile~8. Ability to return for all study assessments~9. Clinically euthyroid, or on stable thyroid replacement therapy~Exclusion Criteria:~1. Subjects who are unable to comply with study requirements~2. Indication, in the opinion of the principal investigator, for urgent surgery that would preclude the time needed for PET-CT scanning~3. History of an inherited mitochondrial disorder (e.g., Leber's hereditary neuropathy; neuropathy; ataxia, retinitis pigmentosa and ptosis \[NARP\]; myoneurogenic gastrointestinal encephalopathy \[MNGIE\]; myocolonic epilepsy with ragged red fibers \[MERFF\]; and mitochondrial myopathy, encephalomyopathy, lactic acidosis and stroke-like syndrome \[MELAS\])~4. Alanine aminotransferase (ALT) \>5x the upper limit of normal (ULN) OR aspartate aminotransferase (AST) \>5X ULN~5. Creatinine clearance \<30 mL/min~6. Body mass that exceeds the rating of the CT table~7. Hypersensitivity to iodine~8. Any condition that would put the subject at reasonable risk in the opinion of the investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- [124I]FIAU (Type: EXPERIMENTAL): Single dose study of \[124I\]FIAU in patients presenting with pain in a prosthetic knee or hip joint who will undergo PET-CT scanning.

Based on this trial design, predict the completion outcome and termination type (if applicable).